Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present at the Joint School of Nanoscience and Nanoengineering (JSNN) NanoImpacts 2022: Semiconductor Synthetic Biology and Beyond taking place October 13-15, 2022 in Greensboro, NC.
Mr. Hellmold will participate in the panel “Perspectives on SemiSynBio: Progress to Date; What’s Missing? And What’s Next?” on Thursday, October 13 at 2:10 PM ET. He will give a keynote speech on Friday, October 14 at 9:00 AM ET on progress being made towards delivering DNA data storage at scale.
The NanoImpacts 2022 Conference highlights progress being made towards achieving goals laid out in the 2018 SemiSynBio Roadmap (SSBR), refines the vision for future initiatives and explores potential synthetic biology and nanomaterial processes and application opportunities beyond the scope of the SSBR.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005222/en/
For Twist Bioscience:
SVP, Corporate Affairs